Schlumberger Announces Redemption of 100% of Outstanding 3.300% Senior Notes Due 2021
As part of its ongoing commitment to debt reduction, Schlumberger Limited (“Schlumberger”) today announced that Schlumberger Investment SA, an indirect wholly-owned subsidiary of Schlumberger (“SISA”), will redeem notes with an outstanding aggregate principal amount of $664,776,000. This redemption is for the entire outstanding principal amount of SISA’s 3.300% Senior Notes due 2021 (CUSIP Nos. 806854AB1 / L81445AB1; and ISIN Nos. US806854AB12 / USL81445AB10) (the “Notes”). The redemption date for the Notes is June 28, 2021 (the “Redemption Date”).
The Notes will be redeemed on the Redemption Date at a redemption price for the Notes equal to (a) 100% of the aggregate principal amount being redeemed, plus (b) accrued and unpaid interest on the Notes from the last interest payment date to, but excluding, the Redemption Date. On and after the Redemption Date, the Notes will cease to be outstanding and interest will cease to accrue on the Notes.
Notices of redemption are being sent by the trustee for the Notes to all currently registered holders of the Notes.
Schlumberger (SLB: NYSE) is a technology company that partners with customers to access energy. Our people, representing over 160 nationalities, are providing leading digital solutions and deploying innovative technologies to enable performance and sustainability for the global energy industry. With expertise in more than 120 countries, Schlumberger collaborates to create technology that unlocks access to energy for the benefit of all.
Find out more at www.slb.com .
Cautionary Statement Regarding Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the federal securities laws — that is, statements about the future, not about past, events. Such statements often contain words such as “expect,” “may,” “believe,” “plan,” “estimate,” “intend,” “anticipate,” “should,” “could,” “will,” “see,” “likely” and other similar words. Forward-looking statements address matters that are, to varying degrees, uncertain, such as statements regarding the terms and timing of the redemption of the Notes. Neither Schlumberger nor SISA can give any assurance that such statements will prove correct. These statements are subject to, among other things, the risks and uncertainties detailed in Schlumberger’s most recent Forms 10-K, 10-Q, and 8-K filed with or furnished to the Securities and Exchange Commission. Actual outcomes may vary materially from those reflected in Schlumberger’s forward-looking statements. The forward-looking statements speak only as of the date of this press release, and Schlumberger and SISA disclaim any intention or obligation to update publicly or revise such statements, whether as a result of new information, future events or otherwise.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MN-PIPER-SANDLER21.6.2021 20:22:10 CEST | Press release
Piper Sandler Advises SK Capital on Sale of Niacet to Kerry
WA-PATTERN-COMPUTER21.6.2021 19:51:07 CEST | Press release
Pattern Computer Discovers New and Novel Methods for Reducing Flight Delays
TBHF21.6.2021 15:47:10 CEST | Press release
Sharjah Honours Kenyan Humanitarian Outfit, RefuSHE, for Pioneering Contributions in Child and Girl-Focused Refugee Development
DEWIZ21.6.2021 15:36:09 CEST | Press release
deWiz Making a Buzz After Closing out Series-A Funding With More Than 5 Million USD Investment
MCG21.6.2021 15:34:08 CEST | Press release
Membership Collective Group Announces Filing of Registration Statement for Proposed Initial Public Offering
NY-AMERICAN-EXPRESS21.6.2021 15:32:08 CEST | Press release
American Express Plans Live Audio Webcast of Second Quarter 2021 Earnings Conference Call
GA-BIOLOG21.6.2021 15:19:06 CEST | Press release
The Blood Center of New Orleans Cooperates With Biolog-id to Enhance Visibility, Availability, and Traceability of Life-saving Blood Components
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom